1. Home
  2. TBPH vs HRTG Comparison

TBPH vs HRTG Comparison

Compare TBPH & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • HRTG
  • Stock Information
  • Founded
  • TBPH 2013
  • HRTG 2012
  • Country
  • TBPH United States
  • HRTG United States
  • Employees
  • TBPH N/A
  • HRTG N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • HRTG Property-Casualty Insurers
  • Sector
  • TBPH Health Care
  • HRTG Finance
  • Exchange
  • TBPH Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • TBPH 699.0M
  • HRTG 590.0M
  • IPO Year
  • TBPH N/A
  • HRTG 2014
  • Fundamental
  • Price
  • TBPH $14.40
  • HRTG $24.10
  • Analyst Decision
  • TBPH Strong Buy
  • HRTG Buy
  • Analyst Count
  • TBPH 4
  • HRTG 3
  • Target Price
  • TBPH $23.00
  • HRTG $29.00
  • AVG Volume (30 Days)
  • TBPH 543.4K
  • HRTG 319.4K
  • Earning Date
  • TBPH 11-11-2025
  • HRTG 11-05-2025
  • Dividend Yield
  • TBPH N/A
  • HRTG N/A
  • EPS Growth
  • TBPH N/A
  • HRTG 76.20
  • EPS
  • TBPH 0.26
  • HRTG 3.47
  • Revenue
  • TBPH $77,205,000.00
  • HRTG $841,666,000.00
  • Revenue This Year
  • TBPH $79.82
  • HRTG $5.15
  • Revenue Next Year
  • TBPH N/A
  • HRTG $6.80
  • P/E Ratio
  • TBPH $55.89
  • HRTG $6.92
  • Revenue Growth
  • TBPH 24.49
  • HRTG 9.57
  • 52 Week Low
  • TBPH $7.88
  • HRTG $8.70
  • 52 Week High
  • TBPH $14.55
  • HRTG $26.64
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 72.80
  • HRTG 56.95
  • Support Level
  • TBPH $13.47
  • HRTG $22.01
  • Resistance Level
  • TBPH $14.42
  • HRTG $24.90
  • Average True Range (ATR)
  • TBPH 0.41
  • HRTG 1.04
  • MACD
  • TBPH -0.05
  • HRTG 0.08
  • Stochastic Oscillator
  • TBPH 86.11
  • HRTG 62.11

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

Share on Social Networks: